ValiRx PLC Grant of options (1088V)

TIDMVAL

RNS Number : 1088V

ValiRx PLC

23 October 2014

23 October 2014

ValiRx Plc

("ValiRx" or the "Company")

Grant of options

ValiRx Plc (AIM: VAL), the AIM-quoted life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that on 22 October 2014, it granted 149,000,000 options over ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to certain employees and directors of the Company, as set out in the table below.

 
 Name of                   Number       % of         Number        Number         Total      Options 
  director              of shares     issued    of existing        of new       options         held 
                             held      share        options       options      now held         as % 
                                     capital                      granted                  of issued 
                                                                                               share 
                                                                                             capital 
 Satu Vainikka         23,113,714      0.79%     35,000,000    24,000,000    59,000,000        2.02% 
 George 
  Morris               18,535,993      0.63%     28,750,000    22,000,000    50,750,000        1.74% 
 Gerry Desler          12,733,921      0.44%     28,400,000    22,000,000    50,400,000        1.73% 
 Kevin Alexander        8,034,843      0.28%     26,400,000    20,000,000    46,400,000        1.59% 
 Oliver 
  de Giorgio-Miller     2,444,411      0.08%     23,000,000    20,000,000    43,000,000        1.47% 
 Seppo Makinen          1,273,387      0.04%      8,000,000    20,000,000    28,000,000        0.96% 
                      -----------  ---------  -------------  ------------  ------------  ----------- 
 Total Directors       66,136,269      2.26%    149,550,000   128,000,000   277,550,000        9.51% 
 
 Other employees              Nil        Nil     23,100,000    21,000,000    44,100,000        1.51% 
 
 Total                 66,136,269      2.26%    172,650,000   149,000,000   321,650,000       11.02% 
                      -----------  ---------  -------------  ------------  ------------  ----------- 
 

The new options were granted under the Company's stock option plan and have an exercise price of 0.36p pence. The new options are exercisable from 22 October 2014 until 21 October 2024.

Following the grant of the new options, the total number of Ordinary Shares under option held by directors, which could be issued, is 277,550,000 Ordinary Shares, representing approximately 9.51 per cent. of the current issued share capital of the Company.

In addition, a further 21,000,000 options have been granted to employees of the Company at an exercise price of 0.36 pence which are exercisable until 21 October 2024.

The issued share capital of the Company comprises 2,921,043,420 ordinary shares of 0.1 pence each.

For more information, please contact:

 
 ValiRx plc                        Tel: [phone] 
                                    4416 
 Dr Satu Vainikka                  www.ValiRx.com 
 
 Cairn Financial Advisers          Tel: [phone] 
  LLP (Nominated Adviser)           7900 
 Liam Murray / Avi Robinson 
 
 Daniel Stewart & Company          Tel: [phone] 
  Plc (Broker)                      6550 
 Martin Lampshire/ Mark Treharne 
 Peckwater PR                      Tel: [phone] 
                                    364 
 Tarquin Edwards                   [e-mail] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSGCBDGGSDBGSX